GB0204392A
GB0204392D0
(en)
|
2002-02-26 |
2002-02-26 |
Pharmaceutical compound
|
SI200330875T
SI1480679T1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
CA2477350A
CA2477350C
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
IL16364203A
IL163642A0
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
BRPI0308023-4A
BRPI0308023B1
(en)
|
2002-02-26 |
2003-02-24 |
CRYSTALLINE FORM OF COMPOUND, COMPOUND AND PHARMACEUTICAL COMPOSITION
|
KR10-2004-7013341A
KR20040086452A
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
CNB038091623A
CN100404032C
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound ZD1839
|
MXPA04008307A
MXPA04008307A
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative.
|
IL16368903A
IL163689A0
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
CA2476587A
CA2476587C
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
MXPA04008330A
MXPA04008330A
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839.
|
AT03708319T
ATE465738T1
(en)
|
2002-02-26 |
2003-02-24 |
NEW CRYSTALLINE FORMS OF THE CANCER-FIGHTING COMPOUND ZD1839
|
JP2003570883A
JP4544863B2
(en)
|
2002-02-26 |
2003-02-24 |
Iressa pharmaceutical formulation containing water-soluble cellulose derivative
|
US10/505,231
US20050163835A1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
PCT/GB2003/000794
WO2003072108A1
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
US10/505,690
US7612077B2
(en)
|
2002-02-26 |
2003-02-24 |
Crystalline forms of the anti-cancer compound ZD1839
|
PT03706732T
PT1480679E
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
AT03706732T
ATE362771T1
(en)
|
2002-02-26 |
2003-02-24 |
PHARMACEUTICAL IRESSA COMPOSITION CONTAINING A WATER-SOLUBLE CELLULOSE DERIVATIVE
|
CA2702297A
CA2702297C
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
EP03706732A
EP1480679B1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
PL372215A
PL208114B1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
DE60313956T
DE60313956T2
(en)
|
2002-02-26 |
2003-02-24 |
PHARMACEUTICAL IRESSA COMPOSITION CONTAINING A WATER SOLUBLE CELLULOSE DERIVATIVE
|
NZ534513A
NZ534513A
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
KR1020047013177A
KR101002374B1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
RU2004129280/15A
RU2318518C2
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical composition possessing anti-proliferative effect (variants), method for its preparing and methods for its using
|
CNB038046164A
CN1326569C
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative
|
EP03708319A
EP1480650B1
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound zd1839
|
PCT/GB2003/000803
WO2003072139A1
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
ES03706732T
ES2286406T3
(en)
|
2002-02-26 |
2003-02-24 |
PHARMACEUTICAL FORMULATION OF IRESSA THAT INCLUDES A WATER SOLUBLE CELLULOSE DERIVATIVE.
|
DK03706732T
DK1480679T3
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
CN2007101823970A
CN101177414B
(en)
|
2002-02-26 |
2003-02-24 |
New crystal form of anti-cancer compound ZD1839, preparation method thereof and medical compound containing the crystal form
|
AU2003208444A
AU2003208444B2
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
NZ534871A
NZ534871A
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound ZD1839
|
JP2003570854A
JP4836404B2
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystal form of anticancer compound ZD1839
|
CN2007101824009A
CN101177415B
(en)
|
2002-02-26 |
2003-02-24 |
Method for preparing new crystal form of anti-cancer compound ZD1839
|
CA2833470A
CA2833470C
(en)
|
2002-02-26 |
2003-02-24 |
Processes for preparing form 1 zd1839 polymorph
|
UA20040907788A
UA76325C2
(en)
|
2002-02-26 |
2003-02-24 |
Iressy, drug containing water-soluble cellulose derivative (variants) and method for its manufacture
|
KR1020107016079A
KR20100090726A
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
MYPI20030631A
MY135609A
(en)
|
2002-02-26 |
2003-02-24 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
AU2003212500A
AU2003212500B2
(en)
|
2002-02-26 |
2003-02-24 |
Novel crystalline forms of the anti-cancer compound ZD1839
|
BRPI0307786A
BRPI0307786B8
(en)
|
2002-02-26 |
2003-02-24 |
pharmaceutical composition, method of preparing the same, methods of inhibiting the rate of precipitation of the agent from solution in the gi tract, and to reduce inter-patient variability with respect to bioavailability and/or plasma concentrations of the agent, and, use of a water-soluble cellulose ether or an ester of a water-soluble cellulose ether
|
DE60332322T
DE60332322D1
(en)
|
2002-02-26 |
2003-02-24 |
NEW CRYSTALLINE SHAPES OF CANCER FIGHTING CONNECTION ZD1839
|
ES03708319T
ES2342660T3
(en)
|
2002-02-26 |
2003-02-24 |
NEW CRYSTAL FORMS OF THE ANTICHANCERIGENO COMPOUND ZD1839.
|
TW092103905A
TWI271193B
(en)
|
2002-02-26 |
2003-02-25 |
Pharmaceutical composition comprising 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline or a pharmaceutically-acceptable salt thereof
|
ARP030100636A
AR038848A1
(en)
|
2002-02-26 |
2003-02-26 |
PHARMACEUTICAL COMPOSITION
|
UY27682A
UY27682A1
(en)
|
2002-02-26 |
2003-02-26 |
PHARMACEUTICAL COMPOSITIONS
|
SA03240043A
SA03240043B1
(en)
|
2002-02-26 |
2003-03-16 |
pharmaceutical composition
|
ZA200406361A
ZA200406361B
(en)
|
2002-02-26 |
2004-08-11 |
Pharmaceutical formulation of iressa comprising a watersoluble cellulose derivative.
|
IL163642A
IL163642A
(en)
|
2002-02-26 |
2004-08-19 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
IL163689A
IL163689A
(en)
|
2002-02-26 |
2004-08-23 |
Crystalline forms of the anti-cancer compound zd1839, processes for their preparation and pharmaceutical compositions comprising them
|
IS7420A
IS2462B
(en)
|
2002-02-26 |
2004-08-24 |
Irresistant formulation containing water-soluble cellulose derivative
|
CO04082661A
CO5601038A2
(en)
|
2002-02-26 |
2004-08-24 |
IRESSA PHARMACEUTICAL FORMULATION THAT INCLUDES A HYDROSOLUBLE CELLULOSE DERIVATIVE
|
ZA200406729A
ZA200406729B
(en)
|
2002-02-26 |
2004-08-24 |
Novel crystalline forms of the anti-cancer compound ZD 1839.
|
NO20043866A
NO328658B1
(en)
|
2002-02-26 |
2004-09-15 |
Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative, preparation thereof, and use thereof
|
NO20044047A
NO329618B1
(en)
|
2002-02-26 |
2004-09-24 |
New crystalline forms of the compound ZD1839, solvate thereof, processes for the preparation thereof and pharmaceutical preparations containing such
|
HK05103350.3A
HK1070582A1
(en)
|
2002-02-26 |
2005-04-19 |
Novel crystalline forms of the anti-cancer compound zd1839
|
HK05103383A
HK1070585A1
(en)
|
2002-02-26 |
2005-04-20 |
Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
|
CY20071100974T
CY1108026T1
(en)
|
2002-02-26 |
2007-07-20 |
IRESSA PHARMACEUTICAL STANDARDIZATION INCLUDING A WATER SOLUTION CELLULAR PRODUCER
|
US12/234,321
US20090186890A1
(en)
|
2002-02-26 |
2008-09-19 |
Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative
|
US12/561,835
US20100137304A1
(en)
|
2002-02-26 |
2009-09-17 |
Novel crystalline forms of the anti-cancer compound zd1839
|